Rosuvastatin/telmisartan - Ildong PharmaceuticalAlternative Names: Telotan; TR Tab
Latest Information Update: 30 Nov 2015
At a glance
- Originator Ildong Pharmaceutical
- Class Antihyperlipidaemics; Antihypertensives; Benzimidazoles; Benzoates; Fluorobenzenes; Pyrimidines; Small molecules; Sulfonamides
- Mechanism of Action ACE inhibitors; Angiotensin type 1 receptor antagonists; HMG-CoA reductase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase III Hyperlipidaemia
Most Recent Events
- 05 Mar 2014 Phase-III clinical trials in Hyperlipidaemia in South Korea (PO)